Bayer's Expert Mondays 2024

  • 16:00, 26 Feb 24 - 17:30, 9 Dec 24
  • Online, Online
  • Print page

Bayer's Expert Mondays – Knowledge Sharing to Empower Your Innovation Journey including Meet & Greet with Bayer Pharma Scouts!

Calling again pre-seed and seed innovators in Cell & Gene, Oncology, Cardiovascular, Immunology, Radiology!

Do you have disruptive breakthrough innovation but are challenged by bringing great science to life and navigating entrepreneurial waters? At Bayer, we’re passionate about enabling and supporting great ideas in healthcare!

Join our Bayer´s Expert Mondays sessions. Each session is dedicated to a specific topic, designed to empower you and your teams. From the future of Clinical Operations to the recent EU Legislative proposal or Cell & Gene topics around market access or regulatory, we’ve got you covered. Gain valuable insights on how to master the art of pitching, approach VCs, and demystify Big Pharma’s Due Diligence or Pharma-Academia Relationships. Get to know Bayer´s incubation programs and partnership models! Each session offers live Q&A with the respective experts and each session is followed by extra time for a live Meet & Greet with Bayer Scouts & Scientific Finders.

Bayer´s Expert Monday´s Session 2024 are hosted by the Collaborate to Cure Hubs EMEA & US!

Please find all sessions, dates, speakers, and topics in the registration link!

See you on selected Mondays at 5 p.m. CET (4 p.m UTC) February - December 2024.

 

 

Theme

Date




Subject

white: All innovation
blue: C&G focus 

Experts

Grow Your Innovation & Get it to Market 

26 Feb

Clinical Operations in 2050

Dr. Bernhard Glombitza

VP, Head of Clinical OPS EMEA & APAC

11 March

EU Legislative Impact on Emerging European Innovation

Dr. Daniel Steiners

SVP, General Manager Bayer Pharma Germany

 

Edouard Ohleyer

Access & Value Policy Lead, Global Pharma Public Affairs

22 April

Cell & Gene Market Access Planning Differences in EMEA & US 

Dr. Markus Frick 

Global Market Access Lead, Cell & Gene

13 May

Cell & Gene Regulatory Jungle in the EU & US

Dr. Isabelle Stoeckert

 VP, Head RA EMEA

 

Dr. Gabriele Bräunlich

VP, RA EMEA, Head RA Strategy

 

Dr. Jana Napolitano

RA Strategy, New Modalities 

Prepare for Dealmaking

15 April

Global Deal Trends, incl. Cell & Gene deals

Yan Jiang

Sr. Dir. BD&L, BD Insights

24 June

How does Big Pharma Evaluate Partnering Offers? + Tips on Preparing Non-Conf. Pitch Decks

Sebastian Karrer

Head of BD&L EMEA CtC Hub EMEA

 

Tanja Bloser

Ecosystem Activation, CtC Hub EMEA

29 July

Catching the Attention of VCs, Investment Banks, and Strategic Investors like Big Pharma

Dr. Vishal Patel

Senior Director BD&L, Strategy

Collaboration

Incubation

Manufacturing

26 Aug

Co.Lab Global Incubators & Cell & Gene Translational Center Berlin

Dr. JP Kruse

Senior Director BD&L, Co.Lab Berlin

 

Dr. Daniel Forler

Senior Director BD&L 

30 Sept

Demystify Due Diligence with Big Pharma

Dr. Anja Moews &
Dr. Torsten Hertramp

Senior Directors BD&L, Due Diligence Center of Excellence

21 Oct

Partnering with Academia from the Pharma Perspective

Dr. Christopher Paschall

Director BD&L, CtC Hub US

18 Nov

Overcome Challenges & Risks in Cell & Gene Manufacturing/CMC Development

Dr. Jens Vogel

SVP, Global Head of Biotech

2 Dec

Bayer´s Collaboration Models & Alliance Management

Dr. Hanna Eilken & Dr. Christoph Huwe

Senior Directors BD&L, Alliance Management

9 Dec 

Ingredients to Successful Partnerships with Bayer

Nicolas Becker Jeremy Booth

Senior Directors BD&L, Alliance Management

Free

 

Register